Phebra
Australian pharmaceutical developer, manufacturer and supplier focused on critical-care, specialty and hospital medicines. The company markets a portfolio of approved and restricted (healthcare-professional-only) products across multiple therapeutic areas, publishes product monographs and consumer medicine information, and operates an online ordering platform for Australian customers.
Industries
Nr. of Employees
medium (51-250)
Products
Acetylcysteine concentrated injection
Parenteral acetylcysteine indicated as an antidote for paracetamol (acetaminophen) poisoning; supplied as concentrated solution in vials.
Hydrochlorothiazide tablets (25 mg)
Oral tablet formulation of hydrochlorothiazide indicated for hypertension and oedema.
Caffeine citrate oral solution (25 mg/5 mL)
Oral solution of caffeine citrate indicated for short-term treatment of apnoea of prematurity in preterm infants.
Arsenic trioxide injection (10 mg/10 mL)
Antineoplastic injectable solution indicated for induction and consolidation therapy in selected patients with acute promyelocytic leukemia (APL).
Methylene blue injection (10 mg/mL)
Parenteral methylene blue indicated for treatment of methemoglobinemia and used as a diagnostic/surgical dye.
Propylthiouracil tablets (50 mg)
Oral tablets indicated for medical management of hyperthyroidism and related clinical uses.
Acetylcysteine concentrated injection
Parenteral acetylcysteine indicated as an antidote for paracetamol (acetaminophen) poisoning; supplied as concentrated solution in vials.
Hydrochlorothiazide tablets (25 mg)
Oral tablet formulation of hydrochlorothiazide indicated for hypertension and oedema.
Caffeine citrate oral solution (25 mg/5 mL)
Oral solution of caffeine citrate indicated for short-term treatment of apnoea of prematurity in preterm infants.
Arsenic trioxide injection (10 mg/10 mL)
Antineoplastic injectable solution indicated for induction and consolidation therapy in selected patients with acute promyelocytic leukemia (APL).
Methylene blue injection (10 mg/mL)
Parenteral methylene blue indicated for treatment of methemoglobinemia and used as a diagnostic/surgical dye.
Propylthiouracil tablets (50 mg)
Oral tablets indicated for medical management of hyperthyroidism and related clinical uses.
Services
Manufacture and commercial supply of a portfolio of approved and restricted medicines across hospital and specialty therapeutic areas.
Web-based ordering system enabling Australian customers to place pharmaceutical orders directly.
Manufacture and commercial supply of a portfolio of approved and restricted medicines across hospital and specialty therapeutic areas.
Web-based ordering system enabling Australian customers to place pharmaceutical orders directly.
Expertise Areas
- Critical care and hospital medicines
- Pharmaceutical formulation and development
- Sterile injectable manufacturing
- Oral solid and liquid dosage manufacturing
Key Technologies
- Sterile parenteral formulation and vial filling
- Lyophilization (freeze-drying)
- Oral solution formulation
- Tablet formulation and compression